| 1 | Joshua Tepper | President and Chief Executive Officer | $379,052 | $380,190 | |
| 2 | Irfan Dhalla | Vice President, Evidence Development and Standards / Vice-président, Analyse des données et normes | $287,002 | $288,064 | |
| 3 | Jennifer Schipper | Chief, Communications and Patient Engagement / Chef, Communications et participation des patients | $249,612 | $250,548 | |
| 4 | Lee Fairclough | Vice President, Quality Improvement / Vice President, Amélioration de la qualité | $227,007 | $227,815 | |
| 5 | Lenna Bradburn | Interim Executive Director, Patient Ombudsman / Directeur général par intérim, Ombudsman des patients | $190,246 | $191,905 | |
| 6 | Anna Greenberg | Vice President, Health System Performance / Vice-présidente, Rendement du système de santé | $174,357 | $175,043 | |
| 7 | Jeffrey Turnbull | Chief, Clinical Quality / Chef, Qualité clinique | $166,173 | $166,173 | |
| 8 | Sudha Kutty | Director, Quality Improvement and Adoption Strategies / Directeur, Amélioration de la qualité et stratégie d'adoption | $145,985 | $146,663 | |
| 9 | Mark Fam | Vice President, Corporate Services / Vice-présidente, Affaires générales et chef des opérations | $144,194 | $144,909 | |
| 10 | Susan Taylor | Director, Quality Improvement Program Delivery / Directeur, Prestation des programmes d'amélioration de la qualité | $136,619 | $137,239 | |